Good Bad Billionaire cover image

Kiran Mazumdar-Shaw: Beer, brewing and biotech

Good Bad Billionaire

CHAPTER

Biocon's Bold Shift: From Brewing to Biotech

This chapter explores Biocon's strategic pivot to the pharmaceutical sector, emphasizing its success in manufacturing generic medicines and producing insulin. It highlights the company's IPO triumph, the rise of its self-made billionaire leader, and the controversies faced during its ambitious journey in the global market.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner